Ingevity Corp
NYSE:NGVT
Balance Sheet
Balance Sheet Decomposition
Ingevity Corp
Current Assets | 669.2m |
Cash & Short-Term Investments | 88.5m |
Receivables | 191.3m |
Other Current Assets | 389.4m |
Non-Current Assets | 1.9B |
Long-Term Investments | 94.1m |
PP&E | 726.5m |
Intangibles | 828.7m |
Other Non-Current Assets | 248.4m |
Current Liabilities | 351.7m |
Accounts Payable | 153.1m |
Accrued Liabilities | 70.5m |
Other Current Liabilities | 128.1m |
Non-Current Liabilities | 1.6B |
Long-Term Debt | 1.4B |
Other Non-Current Liabilities | 238.3m |
Balance Sheet
Ingevity Corp
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
20
|
32
|
31
|
88
|
78
|
57
|
258
|
275
|
77
|
96
|
|
Cash Equivalents |
20
|
32
|
31
|
88
|
78
|
57
|
258
|
275
|
77
|
96
|
|
Total Receivables |
115
|
108
|
106
|
111
|
142
|
175
|
167
|
191
|
249
|
211
|
|
Accounts Receivables |
108
|
95
|
90
|
100
|
124
|
156
|
154
|
167
|
231
|
193
|
|
Other Receivables |
7
|
12
|
16
|
11
|
18
|
19
|
13
|
24
|
18
|
18
|
|
Inventory |
130
|
149
|
151
|
160
|
191
|
213
|
189
|
241
|
335
|
309
|
|
Other Current Assets |
6
|
8
|
7
|
10
|
11
|
19
|
15
|
17
|
18
|
43
|
|
Total Current Assets |
271
|
296
|
295
|
369
|
423
|
463
|
629
|
725
|
679
|
659
|
|
PP&E Net |
410
|
438
|
423
|
439
|
524
|
719
|
754
|
772
|
855
|
829
|
|
PP&E Gross |
410
|
438
|
423
|
439
|
524
|
719
|
754
|
772
|
855
|
829
|
|
Accumulated Depreciation |
440
|
445
|
497
|
523
|
537
|
555
|
600
|
656
|
711
|
819
|
|
Intangible Assets |
13
|
21
|
18
|
23
|
141
|
419
|
397
|
379
|
456
|
385
|
|
Goodwill |
13
|
12
|
12
|
12
|
131
|
436
|
445
|
442
|
519
|
528
|
|
Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
35
|
110
|
99
|
|
Other Long-Term Assets |
11
|
12
|
84
|
87
|
97
|
104
|
110
|
116
|
118
|
123
|
|
Other Assets |
13
|
12
|
12
|
12
|
131
|
436
|
445
|
442
|
519
|
528
|
|
Total Assets |
718
N/A
|
779
+8%
|
833
+7%
|
930
+12%
|
1 315
+41%
|
2 142
+63%
|
2 335
+9%
|
2 469
+6%
|
2 737
+11%
|
2 623
-4%
|
|
Liabilities | |||||||||||
Accounts Payable |
96
|
65
|
79
|
83
|
93
|
99
|
104
|
126
|
175
|
158
|
|
Accrued Liabilities |
30
|
23
|
39
|
56
|
72
|
76
|
81
|
108
|
116
|
94
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
3
|
9
|
8
|
9
|
11
|
23
|
26
|
20
|
1
|
84
|
|
Other Current Liabilities |
10
|
2
|
11
|
4
|
8
|
18
|
13
|
16
|
12
|
26
|
|
Total Current Liabilities |
139
|
100
|
137
|
153
|
183
|
216
|
223
|
269
|
304
|
363
|
|
Long-Term Debt |
86
|
80
|
481
|
444
|
741
|
1 228
|
1 267
|
1 250
|
1 473
|
1 383
|
|
Deferred Income Tax |
69
|
75
|
71
|
43
|
42
|
112
|
130
|
130
|
119
|
86
|
|
Minority Interest |
3
|
4
|
8
|
14
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
4
|
7
|
10
|
11
|
11
|
55
|
71
|
146
|
143
|
160
|
|
Total Liabilities |
301
N/A
|
265
-12%
|
706
+166%
|
666
-6%
|
977
+47%
|
1 611
+65%
|
1 692
+5%
|
1 795
+6%
|
2 038
+14%
|
1 992
-2%
|
|
Equity | |||||||||||
Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
0
|
0
|
130
|
143
|
314
|
497
|
678
|
796
|
1 008
|
1 002
|
|
Additional Paid In Capital |
0
|
0
|
16
|
140
|
98
|
113
|
121
|
136
|
153
|
165
|
|
Treasury Stock |
0
|
0
|
0
|
8
|
56
|
75
|
162
|
272
|
416
|
510
|
|
Other Equity |
417
|
514
|
19
|
12
|
18
|
5
|
5
|
13
|
47
|
27
|
|
Total Equity |
417
N/A
|
514
+23%
|
127
-75%
|
264
+108%
|
339
+28%
|
531
+57%
|
642
+21%
|
674
+5%
|
698
+4%
|
631
-10%
|
|
Total Liabilities & Equity |
718
N/A
|
779
+8%
|
833
+7%
|
930
+12%
|
1 315
+41%
|
2 142
+63%
|
2 335
+9%
|
2 469
+6%
|
2 737
+11%
|
2 623
-4%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
42
|
42
|
42
|
42
|
42
|
42
|
41
|
39
|
37
|
36
|